JP Morgan Upgrades Teva Pharmaceutical Indus to Neutral

JP Morgan upgrades Teva Pharmaceutical Indus (NYSE:TEVA) from Underweight to Neutral.

Benzinga · 11/12/2019 11:36

JP Morgan upgrades Teva Pharmaceutical Indus (NYSE:TEVA) from Underweight to Neutral.